Company Filing History:
Years Active: 2021-2025
Title: Randi M Simmons: Innovator in Immunomodulatory Antibodies
Introduction
Randi M Simmons is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunology, particularly in the development of antibodies that target specific cells involved in cancer treatment. With a total of 4 patents to her name, Simmons is recognized for her innovative approaches to medical therapies.
Latest Patents
Among her latest patents are "Immunomodulatory antibodies and methods of use thereof" and "Human CD163 antibodies and uses thereof." These patents describe antibodies that bind to CD163 on cells, such as macrophages. The methods outlined in these patents can be utilized in treating various forms of cancer, showcasing her commitment to advancing cancer therapies.
Career Highlights
Randi M Simmons currently works at OncoResponse, Inc., where she continues to develop groundbreaking treatments. Her work has positioned her as a key figure in the field of immunotherapy, contributing to the understanding and application of antibodies in clinical settings.
Collaborations
Simmons collaborates with notable colleagues, including Kamal D Puri and Siddarth Chandrasekaran. These partnerships enhance her research and development efforts, fostering innovation in the medical field.
Conclusion
Randi M Simmons is a trailblazer in the development of immunomodulatory antibodies, with a focus on cancer treatment. Her contributions through her patents and work at OncoResponse, Inc. highlight her dedication to improving patient outcomes in oncology.